Back to Journals » Infection and Drug Resistance » Volume 17

Prevalence and Antimicrobial Sensitivity Patterns of Uropathogens in Wad Medani, Sudan: A Three Year, Cross-Sectional Study [Response to Letter]

Authors Hamadalneel YB 

Received 24 June 2024

Accepted for publication 28 June 2024

Published 3 July 2024 Volume 2024:17 Pages 2733—2734

DOI https://doi.org/10.2147/IDR.S484067



Yousif B Hamadalneel

Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan

Correspondence: Yousif B Hamadalneel, Email [email protected]


View the original paper by Dr Hamadalneel and colleagues

This is in response to the Letter to the Editor


Dear editor

We appreciate the Akollo review’s thorough and constructive comments on our work, “Prevalence and Antimicrobial Sensitivity Patterns of Uropathogens in Wad Medani, Sudan: A Three Year, Cross-Sectional Study”. We have given careful thought to every criticism. The following outlines our responses to the main points raised by the reviewers:

Concerning the first point: Firstly, our study was retrospective; one of the most important disadvantages of this study design is missed data. Secondly, our study was laboratory-based; the data were obtained from investigation reports rather than patient records, and we clearly covered this point in the limitations section of our study. Therefore, controlling these confounding factors is more applicable in prospective studies.

Concerning the second point: we agree that uropathogens exhibit temporal trends or seasonal variations. Given that our study was conducted in Sudan, which is one of the sub-Saharan African countries where there is climatic change and overlapping seasons, it is challenging to determine the exact dates of the seasons. As an alternative, we examined uropathogens that were isolated based on survey years in order to identify any changes that might have happened.

Once again, we appreciate your insightful comments.

Disclosure

The author reports no conflicts of interest in this communication.

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.